# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-23-031424
Filing Date
2023-11-13
Accepted
2023-11-13 09:10:31
Documents
69
Period of Report
2023-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-Q | atos20230930_10q.htm iXBRL | 10-Q | 1161342
2 | EXHIBIT 31.1 | ex_566070.htm | EX-31.1 | 11197
3 | EXHIBIT 31.2 | ex_566071.htm | EX-31.2 | 11098
4 | EXHIBIT 32.1 | ex_566072.htm | EX-32.1 | 5999
5 | EXHIBIT 32.2 | ex_566073.htm | EX-32.2 | 5992
11 |  | slidepage17small.jpg | GRAPHIC | 52246
| Complete submission text file | 0001437749-23-031424.txt |  | 4960097

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA | atos-20230930.xsd | EX-101.SCH | 50589
7 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | atos-20230930_cal.xml | EX-101.CAL | 34073
8 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | atos-20230930_def.xml | EX-101.DEF | 311644
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | atos-20230930_lab.xml | EX-101.LAB | 275189
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | atos-20230930_pre.xml | EX-101.PRE | 338923
63 | EXTRACTED XBRL INSTANCE DOCUMENT | atos20230930_10q_htm.xml | XML | 587746

Mailing Address 107 SPRING STREET SEATTLE WA 98104
Business Address 107 SPRING STREET SEATTLE WA 98104 206.588.0256
ATOSSA THERAPEUTICS, INC. (Filer) CIK: 0001488039 (see all company filings)

EIN.: 264753208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35610 | Film No.: 231395694
SIC: 2834 Pharmaceutical Preparations